← Back to home
Comparison · Analytics

Fulcrum vs pharmaversesdtm

A side-by-side editorial comparison of Fulcrum and pharmaversesdtm — release velocity, themes, recent moves, and the top alternatives to consider.

Fulcrum vs pharmaversesdtm: at a glance

FeatureFulcrumpharmaversesdtm
SectorAnalyticsAnalytics
Velocity score6.30.0
Sparks · 30d00
Top themesgis, esri-migration, offline-maps, field-data-capturepharmaverse, sdtm, cdisc, test-data
Last editorial update4h ago5d ago
WebsiteVisit →

What is Fulcrum?

Fulcrum is betting its whole map stack on Esri, with a hard Google Maps cutoff on September 1.

Fulcrum is a field data collection platform, and nearly every entry in the last month touches mapping. The web app ships weekly fix batches for layer rendering (KML/KMZ, MBTiles, ArcGIS Feature Services), while iOS and Android push near-weekly builds against the ArcGIS SDK. The newest iOS build turns to app-level responsiveness - database queries moved off the main path and the record editor kept interactive while Photo FastFill works in the background.

Read the full Fulcrum trajectory →

What is pharmaversesdtm?

pharmaversesdtm is the test-data layer every pharmaverse package now builds against.

The package ships example SDTM datasets and has grown one therapeutic area at a time — ophthalmology, oncology response criteria, vaccines, metabolic, neurology, and now lymphoma under Lugano 2014. Sibling packages keep moving their internal test data here, so its release notes double as a record of what the rest of the pharmaverse is building.

Read the full pharmaversesdtm trajectory →

Fulcrum vs pharmaversesdtm: editorial side-by-side

F
Fulcrum
ANALYTICS
6.3

Fulcrum is betting its whole map stack on Esri, with a hard Google Maps cutoff on September 1.

◆ Current state

Fulcrum is a field data collection platform, and nearly every entry in the last month touches mapping. The web app ships weekly fix batches for layer rendering (KML/KMZ, MBTiles, ArcGIS Feature Services), while iOS and Android push near-weekly builds against the ArcGIS SDK. The newest iOS build turns to app-level responsiveness - database queries moved off the main path and the record editor kept interactive while Photo FastFill works in the background.

◆ Where it's heading

The direction is a full consolidation onto Esri. The legacy Google Maps engine retires on September 1 with automatic migration for anyone who has not switched, and Esri now carries Google's satellite and street basemaps so the imagery argument is neutralized. Underneath, the mobile SDK moved to ArcGIS 300.0.0 and ONNX on-device inference gave way to a new INFERENCE format. Two capabilities are visibly staged behind early access rather than shipped: Photo FastFill, and a GPS integration still described as Alpha.

◆ Prediction

Expect the weeks before September 1 to stay dominated by migration-shaped fixes and Esri parity work, with Photo FastFill the nearer of the two early-access programs to general availability given it is already running in shipped builds.

P0.0

pharmaversesdtm is the test-data layer every pharmaverse package now builds against.

◆ Current state

The package ships example SDTM datasets and has grown one therapeutic area at a time — ophthalmology, oncology response criteria, vaccines, metabolic, neurology, and now lymphoma under Lugano 2014. Sibling packages keep moving their internal test data here, so its release notes double as a record of what the rest of the pharmaverse is building.

◆ Where it's heading

Two kinds of work alternate: adding domains and biomarkers for a new indication, and making the existing data easier to reach — CSV copies under inst/extdata for non-R programmers, a datasets preview vignette, reference pages categorised by therapeutic area, variable-by-variable breakdowns. Consistency fixes against CDISC terminology and SDTM guidelines run through every release.

◆ Prediction

New therapeutic areas will keep arriving in step with the admiral extension packages that need them; the neurology and metabolic datasets landed just ahead of admiralneuro and admiralmetabolic needing them, and lymphoma looks like the next in that sequence.

Alternatives to Fulcrum and pharmaversesdtm

Other Analytics products tracked by Sparkpulse, ranked by recent ship velocity. Each card links to a full editorial trajectory and lets you pivot into a head-to-head comparison with either Fulcrum or pharmaversesdtm.

See all Fulcrum alternatives → · See all pharmaversesdtm alternatives →

Recent activity from Fulcrum and pharmaversesdtm

Latest ship moves from both products, interleaved chronologically. ⚡ = editorial spark.

  1. 1d agoFulcrumiOS: async database queries, non-blocking Photo FastFill
  2. 5d agoFulcrumWeb fixes: shared-view exports, MBTiles popups, KML and ArcGIS layers
  3. 7d agoFulcrumAndroid: update offline map layers in place, non-blocking Photo FastFill
  4. 8d agoFulcrumiOS fix: slow location resolution blocked record saves
  5. 13d agoFulcrumWeb: SSO email wording and ArcGIS/deck.gl version bumps
  6. 14d agoFulcrumAndroid fixes: ArcGIS stability, signature button, photo markup
  7. 1mo agopharmaversesdtmLymphoma response data and geographic-atrophy tests
  8. 4mo agopharmaversesdtmCSV exports and microbiology domains for wider access
  9. 7mo agopharmaversesdtmNeurological SDTM datasets and Alzheimer's biomarkers
  10. 0y agopharmaversesdtmMaintainer and licensing update
  11. 1y agopharmaversesdtmMetabolic SDTM datasets and PCWG3 oncology response
  12. 1y agopharmaversesdtmGCIG response data and automated reference pages

Frequently asked questions

What is the difference between Fulcrum and pharmaversesdtm?

They serve adjacent needs but don't currently overlap on shipped themes. Fulcrum is currently shipping more aggressively (velocity 6.3 vs 0.0), with 0 editorial sparks in the last 30 days against 0. See the at-a-glance table above for a side-by-side breakdown of velocity, recent sparks, and editorial themes.

Is Fulcrum better than pharmaversesdtm?

Sparkpulse doesn't pick a winner — we score release velocity, not feature parity. Fulcrum is currently shipping more aggressively (velocity 6.3 vs 0.0), with 0 editorial sparks in the last 30 days against 0. For your specific use case, the alternatives sections above list other Analytics products to evaluate alongside.

What are the best alternatives to Fulcrum?

Top Fulcrum alternatives in Analytics are ranked by recent ship velocity. Browse the "Fulcrum alternatives" section above for the current picks, or visit /alternatives/fulcrum for the full list with editorial commentary on each.

What are the best alternatives to pharmaversesdtm?

Top pharmaversesdtm alternatives in Analytics are ranked by recent ship velocity. Browse the "pharmaversesdtm alternatives" section above for the current picks, or visit /alternatives/pharmaversesdtm for the full list with editorial commentary on each.